$1.72 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 203 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 159.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | STRYKER CORPORATIONput | $58,684,000 | +192.7% | 295,000 | +293.3% | 3.41% | +424.3% | |
| Buy | LIVANOVA PLCcall | $54,293,000 | +73.9% | 869,100 | +127.8% | 3.15% | +211.3% | |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $53,766,000 | -17.1% | 988,713 | +2.7% | 3.12% | +48.5% |
| CUTR | Buy | CUTERA INC | $41,931,000 | -43.4% | 1,118,158 | +4.1% | 2.44% | +1.3% |
| INSP | Buy | INSPIRE MED SYS INC | $37,350,000 | -28.5% | 204,465 | +0.5% | 2.17% | +28.0% |
| VRAY | Buy | VIEWRAY INC | $36,753,000 | -30.9% | 13,869,108 | +2.3% | 2.14% | +23.8% |
| GKOS | New | GLAUKOS CORP | $36,182,000 | – | 796,600 | +100.0% | 2.10% | – |
| Buy | FIRST TR EXCHANGE TRADED FDput | $34,030,000 | +48.4% | 330,000 | +65.0% | 1.98% | +165.6% | |
| New | IDEXX LABS INCput | $29,812,000 | – | 85,000 | +100.0% | 1.73% | – | |
| New | VANECK ETF TRUSTput | $23,052,000 | – | 300,000 | +100.0% | 1.34% | – | |
| Buy | ABBOTT LABSput | $21,730,000 | -5.8% | 200,000 | +2.6% | 1.26% | +68.7% | |
| Buy | METTLER TOLEDO INTERNATIONALput | $20,103,000 | +33.1% | 17,500 | +59.1% | 1.17% | +138.4% | |
| LUNG | Buy | PULMONX CORP | $19,534,000 | +33.5% | 1,327,065 | +125.0% | 1.13% | +139.2% |
| GH | Buy | GUARDANT HEALTH INC | $18,939,000 | +318.2% | 469,492 | +586.6% | 1.10% | +648.3% |
| Buy | GUARDANT HEALTH INCcall | $18,758,000 | +3.0% | 465,000 | +69.1% | 1.09% | +84.3% | |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $18,663,000 | -56.0% | 1,469,547 | +20.4% | 1.08% | -21.2% |
| OCX | Buy | ONCOCYTE CORP | $16,245,000 | -10.8% | 18,056,274 | +47.7% | 0.94% | +59.6% |
| Buy | CELLDEX THERAPEUTICS INC NEWcall | $16,036,000 | +18.7% | 594,800 | +50.0% | 0.93% | +112.6% | |
| New | PERKINELMER INCput | $15,644,000 | – | 110,000 | +100.0% | 0.91% | – | |
| New | PENUMBRA INCput | $15,565,000 | – | 125,000 | +100.0% | 0.90% | – | |
| New | BRISTOL-MYERS SQUIBB COput | $15,400,000 | – | 200,000 | +100.0% | 0.89% | – | |
| Buy | HEALTHEQUITY INCcall | $15,348,000 | +26.4% | 250,000 | +38.9% | 0.89% | +126.1% | |
| Buy | PRIVIA HEALTH GROUP INCcall | $15,288,000 | +90.6% | 525,000 | +75.0% | 0.89% | +241.5% | |
| LYRA | Buy | LYRA THERAPEUTICS INC | $14,556,000 | +595.5% | 2,576,196 | +394.9% | 0.84% | +1142.6% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $14,292,000 | +381.1% | 60,650 | +266.2% | 0.83% | +764.6% |
| Buy | MOLSON COORS BEVERAGE COput | $14,080,000 | +20.8% | 258,300 | +18.3% | 0.82% | +116.4% | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $13,891,000 | – | 95,240 | +100.0% | 0.81% | – |
| New | ALIGN TECHNOLOGY INCput | $13,017,000 | – | 55,000 | +100.0% | 0.76% | – | |
| New | BIONTECH SEcall | $11,928,000 | – | 80,000 | +100.0% | 0.69% | – | |
| New | ILLUMINA INCput | $11,062,000 | – | 60,000 | +100.0% | 0.64% | – | |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $10,758,000 | +440.6% | 162,828 | +442.8% | 0.62% | +861.5% |
| Buy | MEDPACE HLDGS INCput | $10,477,000 | +113.5% | 70,000 | +133.3% | 0.61% | +282.4% | |
| COO | Buy | COOPER COS INC | $10,176,000 | +87.4% | 32,500 | +150.0% | 0.59% | +235.8% |
| New | INTELLIA THERAPEUTICS INCput | $10,083,000 | – | 194,800 | +100.0% | 0.59% | – | |
| New | CANOPY GROWTH CORPput | $9,975,000 | – | 3,500,000 | +100.0% | 0.58% | – | |
| New | TANDEM DIABETES CARE INCput | $9,470,000 | – | 160,000 | +100.0% | 0.55% | – | |
| New | ALCON AGput | $9,435,000 | – | 135,000 | +100.0% | 0.55% | – | |
| New | OUTSET MED INCcall | $8,886,000 | – | 598,000 | +100.0% | 0.52% | – | |
| Buy | HCA HEALTHCARE INCput | $8,403,000 | +67.7% | 50,000 | +150.0% | 0.49% | +199.4% | |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $7,998,000 | +1211.1% | 812,828 | +1863.7% | 0.46% | +2225.0% |
| New | ARK ETF TRcall | $7,976,000 | – | 200,000 | +100.0% | 0.46% | – | |
| APYX | Buy | APYX MEDICAL CORPORATION | $7,755,000 | +20.9% | 1,323,303 | +34.7% | 0.45% | +116.3% |
| Buy | PACIFIC BIOSCIENCES CALIF INput | $7,293,000 | -40.6% | 1,650,000 | +22.2% | 0.42% | +6.5% | |
| QTRX | New | QUANTERIX CORP | $7,083,000 | – | 437,500 | +100.0% | 0.41% | – |
| EVH | Buy | EVOLENT HEALTH INCcl a | $7,063,000 | +9.3% | 230,000 | +15.0% | 0.41% | +96.2% |
| Buy | IVERIC BIO INCcall | $7,019,000 | -21.2% | 729,600 | +37.8% | 0.41% | +41.2% | |
| New | DEXCOM INCput | $7,006,000 | – | 94,000 | +100.0% | 0.41% | – | |
| New | CEREVEL THERAPEUTICS HLDNG Icall | $6,435,000 | – | 243,400 | +100.0% | 0.37% | – | |
| New | NANOSTRING TECHNOLOGIES INCcall | $6,350,000 | – | 500,000 | +100.0% | 0.37% | – | |
| Buy | NOVOCURE LTDput | $6,255,000 | +20.4% | 90,000 | +43.5% | 0.36% | +116.1% | |
| New | ABIOMED INCput | $6,188,000 | – | 25,000 | +100.0% | 0.36% | – | |
| New | TELEFLEX INCORPORATEDput | $6,146,000 | – | 25,000 | +100.0% | 0.36% | – | |
| New | WALGREENS BOOTS ALLIANCE INCput | $5,685,000 | – | 150,000 | +100.0% | 0.33% | – | |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $5,402,000 | – | 50,000 | +100.0% | 0.31% | – |
| New | HENRY SCHEIN INCput | $5,372,000 | – | 70,000 | +100.0% | 0.31% | – | |
| New | ZIMMER BIOMET HOLDINGS INCput | $5,253,000 | – | 50,000 | +100.0% | 0.30% | – | |
| New | R1 RCM INC | $5,234,000 | – | 249,732 | +100.0% | 0.30% | – | |
| AGL | Buy | AGILON HEALTH INC | $5,154,000 | +351.7% | 236,100 | +424.7% | 0.30% | +708.1% |
| Buy | CYTEK BIOSCIENCES INC | $5,120,000 | +11.9% | 477,164 | +12.4% | 0.30% | +100.7% | |
| Buy | ORTHOPEDIATRICS CORPput | $4,962,000 | +67.1% | 115,000 | +109.1% | 0.29% | +200.0% | |
| New | AMERISOURCEBERGEN CORPput | $4,952,000 | – | 35,000 | +100.0% | 0.29% | – | |
| AVTR | New | AVANTOR INC | $4,821,000 | – | 155,000 | +100.0% | 0.28% | – |
| Buy | INMODE LTDput | $4,706,000 | +51.8% | 210,000 | +150.0% | 0.27% | +170.3% | |
| New | KONINKLIJKE PHILIPS N Vput | $4,306,000 | – | 200,000 | +100.0% | 0.25% | – | |
| Buy | GINKGO BIOWORKS HOLDINGS INCput | $4,165,000 | -31.1% | 1,750,000 | +16.7% | 0.24% | +23.5% | |
| BVS | Buy | BIOVENTUS INC | $4,086,000 | -47.9% | 599,080 | +7.8% | 0.24% | -6.7% |
| New | REPLIGEN CORPput | $4,060,000 | – | 25,000 | +100.0% | 0.24% | – | |
| TGTX | Buy | TG THERAPEUTICS INC | $4,041,000 | +29.5% | 950,813 | +189.7% | 0.24% | +132.7% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $4,027,000 | +41.8% | 166,201 | +50.8% | 0.23% | +154.3% |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $3,922,000 | – | 305,000 | +100.0% | 0.23% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $3,854,000 | – | 364,252 | +100.0% | 0.22% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $3,783,000 | – | 29,900 | +100.0% | 0.22% | – |
| Buy | ALNYLAM PHARMACEUTICALS INCcall | $3,690,000 | +83.8% | 25,300 | +105.7% | 0.21% | +229.2% | |
| RCEL | Buy | AVITA MEDICAL INC | $3,524,000 | -38.4% | 741,875 | +10.0% | 0.20% | +10.8% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $3,377,000 | – | 21,643 | +100.0% | 0.20% | – |
| New | AMYRIS INCcall | $3,258,000 | – | 1,761,000 | +100.0% | 0.19% | – | |
| New | KARUNA THERAPEUTICS INCput | $3,226,000 | – | 25,500 | +100.0% | 0.19% | – | |
| Buy | SOPHIA GENETICS SAordinary shares | $3,113,000 | -51.5% | 859,930 | +3.6% | 0.18% | -13.0% | |
| New | TRICIDA INCcall | $3,079,000 | – | 318,100 | +100.0% | 0.18% | – | |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $3,073,000 | – | 183,121 | +100.0% | 0.18% | – |
| HUM | New | HUMANA INC | $2,996,000 | – | 6,400 | +100.0% | 0.17% | – |
| New | PTC THERAPEUTICS INCcall | $2,928,000 | – | 73,100 | +100.0% | 0.17% | – | |
| New | SOMALOGIC INCcall | $2,737,000 | – | 605,500 | +100.0% | 0.16% | – | |
| New | CELLDEX THERAPEUTICS INC NEWput | $2,696,000 | – | 100,000 | +100.0% | 0.16% | – | |
| Buy | GERON CORPcall | $2,639,000 | +176.0% | 1,702,600 | +142.3% | 0.15% | +393.5% | |
| New | INTELLIA THERAPEUTICS INCcall | $2,588,000 | – | 50,000 | +100.0% | 0.15% | – | |
| New | BAUSCH HEALTH COS INCput | $2,508,000 | – | 300,000 | +100.0% | 0.15% | – | |
| New | VERU INCcall | $2,260,000 | – | 200,000 | +100.0% | 0.13% | – | |
| Buy | SCIENCE 37 HOLDINGS INC | $2,224,000 | -58.7% | 1,106,400 | +9.9% | 0.13% | -26.3% | |
| New | IOVANCE BIOTHERAPEUTICS INCcall | $2,208,000 | – | 200,000 | +100.0% | 0.13% | – | |
| PODD | New | INSULET CORP | $2,179,000 | – | 10,000 | +100.0% | 0.13% | – |
| COGT | New | COGENT BIOSCIENCES INC | $2,154,000 | – | 238,787 | +100.0% | 0.12% | – |
| NTRA | New | NATERA INC | $2,132,000 | – | 60,159 | +100.0% | 0.12% | – |
| New | PTC THERAPEUTICS INCnote 3.000% 8/1 | $2,026,000 | – | 20,000 | +100.0% | 0.12% | – | |
| EW | New | EDWARDS LIFESCIENCES CORP | $1,968,000 | – | 20,700 | +100.0% | 0.11% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,926,000 | – | 789,181 | +100.0% | 0.11% | – |
| New | APYX MEDICAL CORPORATIONcall | $1,758,000 | – | 300,000 | +100.0% | 0.10% | – | |
| New | TG THERAPEUTICS INCput | $1,577,000 | – | 371,000 | +100.0% | 0.09% | – | |
| EXEL | New | EXELIXIS INC | $1,562,000 | – | 75,000 | +100.0% | 0.09% | – |
| New | ATARA BIOTHERAPEUTICS INCcall | $1,558,000 | – | 200,000 | +100.0% | 0.09% | – | |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $1,349,000 | – | 212,123 | +100.0% | 0.08% | – |
| LHDX | Buy | LUCIRA HEALTH INC | $1,285,000 | -47.6% | 690,663 | +0.5% | 0.08% | -6.2% |
| New | RADIUS HEALTH INCput | $1,236,000 | – | 119,200 | +100.0% | 0.07% | – | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $1,217,000 | +165.1% | 40,002 | +166.6% | 0.07% | +373.3% |
| Buy | IMMUNIC INCput | $1,164,000 | -65.7% | 335,500 | +11.8% | 0.07% | -38.2% | |
| VSTM | New | VERASTEM INC | $1,165,000 | – | 1,004,272 | +100.0% | 0.07% | – |
| New | RELMADA THERAPEUTICS INCput | $1,158,000 | – | 61,000 | +100.0% | 0.07% | – | |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $1,029,000 | – | 12,900 | +100.0% | 0.06% | – |
| New | LIQUIDIA CORPORATIONput | $1,023,000 | – | 234,700 | +100.0% | 0.06% | – | |
| New | GOSSAMER BIO INCput | $837,000 | – | 100,000 | +100.0% | 0.05% | – | |
| CMRX | New | CHIMERIX INC | $801,000 | – | 384,905 | +100.0% | 0.05% | – |
| New | PLIANT THERAPEUTICS INCcall | $801,000 | – | 100,000 | +100.0% | 0.05% | – | |
| New | STRYVE FOODS INC | $705,000 | – | 800,000 | +100.0% | 0.04% | – | |
| New | CLOVIS ONCOLOGY INCcall | $511,000 | – | 284,000 | +100.0% | 0.03% | – | |
| New | BLUEPRINT MEDICINES CORPput | $505,000 | – | 10,000 | +100.0% | 0.03% | – | |
| New | KARUNA THERAPEUTICS INCcall | $392,000 | – | 3,100 | +100.0% | 0.02% | – | |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $239,000 | – | 6,419 | +100.0% | 0.01% | – |
| ZYME | New | ZYMEWORKS INC | $237,000 | – | 44,696 | +100.0% | 0.01% | – |
| Buy | AMYLYX PHARMACEUTICALS INC | $203,000 | +57.4% | 10,550 | +5.5% | 0.01% | +200.0% | |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $187,000 | – | 44,357 | +100.0% | 0.01% | – |
| New | LEXICON PHARMACEUTICALS INCcall | $167,000 | – | 89,900 | +100.0% | 0.01% | – | |
| New | SPRINGBIG HOLDINGS INC*w exp 06/14/202 | $1,000 | – | 10,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.